More articles from Research letter

Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex (MAC) pulmonary disease
Hadeel Khadawardi, Theodore K. Marras, Mahtab Mehrabi, Sarah K. Brode

European Respiratory Journal Jan 2020, 1901240; DOI: 10.1183/13993003.01240-2019
Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult
Vincent Cottin, Mouhamad Nasser, Julie Traclet, Lara Chalabreysse, Anne-Sophie Lèbre, Salim Si-Mohamed, François Philit, Françoise Thivolet-Béjui

European Respiratory Journal Jan 2020, 1901952; DOI: 10.1183/13993003.01952-2019
Antinuclear Antibodies and Subclinical Interstitial Lung Disease in Community Dwelling Adults: The MESA Study
Elana J. Bernstein, John H.M. Austin, Steven M. Kawut, Ganesh Raghu, Eric A. Hoffman, John D. Newell, Jubal R. Watts, P. Hrudaya Nath, Sushilkumar K. Sonavane, R. Graham Barr, David J. Lederer

European Respiratory Journal Jan 2020, 1902262; DOI: 10.1183/13993003.02262-2019
The utility and safety of Linear Endobronchial Ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the paediatric population
Haider Al-Najjar, Ronan Breen, George Santis, Omendra Narayan

European Respiratory Journal Jan 2020, 1902277; DOI: 10.1183/13993003.02277-2019
Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin
Simone H.J. van den Elsen, Onno W. Akkerman, Erwin M. Jongedijk, Mireille Wessels, Samiksha Ghimire, Tjip S. van der Werf, Daan J. Touw, Mathieu S. Bolhuis, Jan-Willem C. Alffenaar

European Respiratory Journal Jan 2020, 1901903; DOI: 10.1183/13993003.01903-2019
Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in Fibrotic Hypersensitivity Pneumonitis: a retrospective cohort study
Laurens J. De Sadeleer, Frederik Hermans, Els De Dycker, Jonas Yserbyt, Johny A. Verschakelen, Eric K. Verbeken, Geert M. Verleden, Stijn E. Verleden, Wim A. Wuyts

European Respiratory Journal Jan 2020, 1901983; DOI: 10.1183/13993003.01983-2019
The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis
Mark G.J.P. Platenburg, Ivo A. Wiertz, Joanne J. van der Vis, Bruno Crestani, Raphael Borie, Philippe Dieude, Caroline Kannengiesser, Jacobus A. Burgers, Jan C. Grutters, Coline H.M. van Moorsel

European Respiratory Journal Jan 2020, 1902361; DOI: 10.1183/13993003.02361-2019
Blood monocyte counts as a potential prognostic marker for IPF: Analysis from the Australian IPF registry
Alan K. Y. Teoh, Helen E. Jo, Daniel C. Chambers, K. Symons, Eugene H. Walters, Nicole S. Goh, Ian Glaspole, Wendy Cooper, Paul Reynolds, Yuben Moodley, Tamera J. Corte

European Respiratory Journal Jan 2020, 1901855; DOI: 10.1183/13993003.01855-2019
Towards selective tuberculosis screening of people in prison in a low-incidence country
Gerard de Vries, Sylvia Commandeur, Connie Erkens, Walid Haddad, Niesje Jansen, Peter Kouw, Margreet Kamphorst-Roemer

European Respiratory Journal Jan 2019, 1902209; DOI: 10.1183/13993003.02209-2019
SNPs identified by GWAS affect asthma risk through DNA methylation and expression of cis-genes in airway epithelium
Soyeon Kim, Erick Forno, Qi Yan, Yale Jiang, Rong Zhang, Nadia Boutaoui, Edna Acosta-Pérez, Glorisa Canino, Wei Chen, Juan C. Celedón

European Respiratory Journal Jan 2019, 1902079; DOI: 10.1183/13993003.02079-2019

Main menu

User menu

Search

More articles from Research letter

Pages

Contact us